These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21316051)

  • 1. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.
    Çakmak S; Mahiroğulları M; Keklikçi K; Sarı E; Erdik B; Rodop O
    Acta Orthop Traumatol Turc; 2013; 47(3):162-72. PubMed ID: 23748615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous femoral shaft fracture after long-term alendronate.
    Ali T; Jay RH
    Age Ageing; 2009 Sep; 38(5):625-6. PubMed ID: 19556326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-energy femoral shaft fractures associated with alendronate use.
    Neviaser AS; Lane JM; Lenart BA; Edobor-Osula F; Lorich DG
    J Orthop Trauma; 2008; 22(5):346-50. PubMed ID: 18448990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD; McCarthy EF
    Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
    Angthong C; Angthong W
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP
    Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.
    Chan SS; Rosenberg ZS; Chan K; Capeci C
    AJR Am J Roentgenol; 2010 Jun; 194(6):1581-6. PubMed ID: 20489100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoral insufficiency fractures in the elderly - excessive medial femoral bowing complicates intramedullary nailing.
    Özsoy MH; Aksekili MA; Kızılay O; Dinçel VE; Aydoğan NH; Ozsoy A
    Acta Orthop Traumatol Turc; 2014; 48(5):507-12. PubMed ID: 25429575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
    Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
    Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.
    Goh SK; Yang KY; Koh JS; Wong MK; Chua SY; Chua DT; Howe TS
    J Bone Joint Surg Br; 2007 Mar; 89(3):349-53. PubMed ID: 17356148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ng YH, Gino PD, Lingaraj K, Das De S. Femoral shaft fracture in the elderly - role of prior bisphosphonate therapy.
    Haque S; Siddiqui G
    Injury; 2012 Jul; 43(7):1221. PubMed ID: 21555125
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
    Patel VC; Lazzarini AM
    Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.